Treatment of amyotrophic lateral sclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61P 9/00 (2006.01) A61P 25/14 (2006.01)

Patent

CA 2568158

The present invention relates to the treatment of motoneuron diseases. More particularly the invention relates to the treatment of amyotrophic lateral sclerosis (ALS). It is found that the intracerebroventricular delivery of low amounts of vascular endothelial growth factor into a preclinical ALS animal model induces a significant motor performance and prolongation of survival time of said animals.

L'invention concerne un traitement de maladies des motoneurones. En particulier, l'invention concerne le traitement de la sclérose latérale amyotrophique (SLA). Dans l'invention, on a découvert que l'administration intracérébroventriculaire de faibles quantités d'un facteur de croissance endothéliale vasculaire dans un modèle animal SLA préclinique induit une performance moteur et une prolongation significatives de la durée de vie des animaux ayant subi ce traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of amyotrophic lateral sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of amyotrophic lateral sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of amyotrophic lateral sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1398104

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.